NO944311L - Substituerte indoler og azaindoler som angiotensin-II-antagonister - Google Patents
Substituerte indoler og azaindoler som angiotensin-II-antagonisterInfo
- Publication number
- NO944311L NO944311L NO944311A NO944311A NO944311L NO 944311 L NO944311 L NO 944311L NO 944311 A NO944311 A NO 944311A NO 944311 A NO944311 A NO 944311A NO 944311 L NO944311 L NO 944311L
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- hydrogen
- angiotensin
- antagonists
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/882,390 US5212195A (en) | 1992-05-13 | 1992-05-13 | Substituted indole antagonists derivatives which are angiotensin II |
US08/004,869 US5380739A (en) | 1992-05-13 | 1993-02-04 | Substituted indole derivatives |
PCT/US1993/001533 WO1993023391A1 (en) | 1992-05-13 | 1993-02-26 | Substituted indoles and azaindoles as angiotensin ii antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944311D0 NO944311D0 (no) | 1994-11-11 |
NO944311L true NO944311L (no) | 1994-11-14 |
NO308535B1 NO308535B1 (no) | 2000-09-25 |
Family
ID=26673598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944311A NO308535B1 (no) | 1992-05-13 | 1994-11-11 | Substituerte indol-, azaindol- og tetrahydro-1H-pyrrolo[2,3- c]-pyridin-7-on-derivater |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0640080B1 (no) |
JP (1) | JP3332234B2 (no) |
CN (1) | CN1039714C (no) |
AT (1) | ATE159524T1 (no) |
AU (1) | AU672599B2 (no) |
CA (1) | CA2135605A1 (no) |
DE (1) | DE69314786T2 (no) |
DK (1) | DK0640080T3 (no) |
ES (1) | ES2110086T3 (no) |
FI (1) | FI110512B (no) |
GR (1) | GR3025118T3 (no) |
HU (2) | HU221616B1 (no) |
IL (1) | IL104869A (no) |
MX (1) | MX9301088A (no) |
NO (1) | NO308535B1 (no) |
NZ (2) | NZ299146A (no) |
WO (1) | WO1993023391A1 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6569539B2 (en) | 1996-10-30 | 2003-05-27 | Tetra Level Holdings & Finance S.A. | Gas barrier packaging laminate method for production thereof and packaging containers |
US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
EA200000868A1 (ru) * | 1998-02-25 | 2001-04-23 | Дженетикс Инститьют, Инк. | Ингибиторы фосфолипаз |
US6916841B2 (en) | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
AU1887401A (en) * | 1999-12-14 | 2001-06-25 | Nippon Shinyaku Co. Ltd. | Medicinal composition |
WO2002048155A1 (de) * | 2000-12-14 | 2002-06-20 | Clariant Gmbh | Verfahren zur herstellung von formylphenylboronsäuren |
KR20040039430A (ko) * | 2001-09-28 | 2004-05-10 | 이하라케미칼 고교가부시키가이샤 | (2-니트로페닐)아세토니트릴 유도체의 제조방법 및 그합성중간체 |
US6635771B2 (en) | 2001-12-03 | 2003-10-21 | Wyeth | N-benzhydryl indole compounds |
US7101875B2 (en) | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
US7713964B2 (en) | 2001-12-03 | 2010-05-11 | Wyeth Llc | Methods for treating asthmatic conditions |
US7605156B2 (en) | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
US6984735B2 (en) | 2001-12-03 | 2006-01-10 | Wyeth | Process for making an aldehyde |
US6797708B2 (en) | 2001-12-03 | 2004-09-28 | Wyeth | Inhibitors of cytosolic phospholipase A2 |
US7129264B2 (en) * | 2003-04-16 | 2006-10-31 | Bristol-Myers Squibb Company | Biarylmethyl indolines and indoles as antithromboembolic agents |
TW200718687A (en) | 2005-05-27 | 2007-05-16 | Wyeth Corp | Inhibitors of cytosolic phospholipase A2 |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
AU2009210297B2 (en) * | 2008-01-31 | 2013-11-21 | Sanofi | Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
AU2009210296B2 (en) * | 2008-01-31 | 2013-11-14 | Sanofi | Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
CN101940568B (zh) * | 2010-08-17 | 2012-11-14 | 合肥博太医药生物技术发展有限公司 | 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗蒽环抗癌药引起的心脏衰竭药物中的应用 |
CN107056781A (zh) * | 2017-05-18 | 2017-08-18 | 康化(上海)新药研发有限公司 | 一种(E)‑5‑甲基‑1H‑吡咯并[2,3‑b]吡啶‑3‑甲醛肟的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0400835A1 (en) * | 1989-05-15 | 1990-12-05 | Merck & Co. Inc. | Substituted benzimidazoles as angiotensin II antagonists |
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
US5124335A (en) * | 1991-01-30 | 1992-06-23 | Merck & Co., Inc. | Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists |
-
1993
- 1993-02-26 JP JP52017993A patent/JP3332234B2/ja not_active Expired - Fee Related
- 1993-02-26 EP EP93906123A patent/EP0640080B1/en not_active Expired - Lifetime
- 1993-02-26 CN CN93102401A patent/CN1039714C/zh not_active Expired - Fee Related
- 1993-02-26 MX MX9301088A patent/MX9301088A/es not_active IP Right Cessation
- 1993-02-26 WO PCT/US1993/001533 patent/WO1993023391A1/en active IP Right Grant
- 1993-02-26 AU AU37274/93A patent/AU672599B2/en not_active Ceased
- 1993-02-26 IL IL104869A patent/IL104869A/xx not_active IP Right Cessation
- 1993-02-26 AT AT93906123T patent/ATE159524T1/de not_active IP Right Cessation
- 1993-02-26 ES ES93906123T patent/ES2110086T3/es not_active Expired - Lifetime
- 1993-02-26 NZ NZ299146A patent/NZ299146A/en unknown
- 1993-02-26 DK DK93906123.0T patent/DK0640080T3/da active
- 1993-02-26 NZ NZ249729A patent/NZ249729A/en unknown
- 1993-02-26 CA CA002135605A patent/CA2135605A1/en not_active Abandoned
- 1993-02-26 HU HU9403238A patent/HU221616B1/hu not_active IP Right Cessation
- 1993-02-26 DE DE69314786T patent/DE69314786T2/de not_active Expired - Fee Related
-
1994
- 1994-11-11 FI FI945319A patent/FI110512B/fi active
- 1994-11-11 NO NO944311A patent/NO308535B1/no not_active IP Right Cessation
-
1995
- 1995-02-17 HU HU95P/P00076P patent/HU210709A9/hu unknown
-
1997
- 1997-10-23 GR GR970401901T patent/GR3025118T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU210709A9 (en) | 1995-06-28 |
EP0640080B1 (en) | 1997-10-22 |
FI945319A (fi) | 1994-11-11 |
NZ299146A (en) | 2000-06-23 |
CA2135605A1 (en) | 1993-11-25 |
WO1993023391A1 (en) | 1993-11-25 |
JP3332234B2 (ja) | 2002-10-07 |
ATE159524T1 (de) | 1997-11-15 |
CN1039714C (zh) | 1998-09-09 |
AU672599B2 (en) | 1996-10-10 |
MX9301088A (es) | 1993-11-01 |
NO308535B1 (no) | 2000-09-25 |
JPH07506826A (ja) | 1995-07-27 |
ES2110086T3 (es) | 1998-02-01 |
EP0640080A1 (en) | 1995-03-01 |
DE69314786T2 (de) | 1998-02-19 |
DK0640080T3 (da) | 1998-05-25 |
NO944311D0 (no) | 1994-11-11 |
HUT68056A (en) | 1995-05-29 |
NZ249729A (en) | 1996-12-20 |
IL104869A (en) | 1997-11-20 |
HU221616B1 (hu) | 2002-12-28 |
AU3727493A (en) | 1993-12-13 |
DE69314786D1 (de) | 1997-11-27 |
FI110512B (fi) | 2003-02-14 |
GR3025118T3 (en) | 1998-01-30 |
FI945319A0 (fi) | 1994-11-11 |
IL104869A0 (en) | 1993-06-10 |
CN1078469A (zh) | 1993-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944311L (no) | Substituerte indoler og azaindoler som angiotensin-II-antagonister | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
NO20025227D0 (no) | Tropanderivater nyttige i terapi | |
NO20013379D0 (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
NO930817D0 (no) | Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse | |
DE69505470D1 (de) | Pyrrolocarbazol | |
GR3035809T3 (en) | Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones. | |
ATE117677T1 (de) | Indolderivate. | |
MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
ATE170851T1 (de) | Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten | |
DE69423055T2 (de) | Indol Derivate als Glutamat Antagonisten | |
ECSP992845A (es) | Compuestos quimicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |